QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes

Overview

About this study

The purpose of this study is to determine whether usual care with the QBSafe intervention (comprised of conversation cards and materials) compared with usual care alone improves patient reported outcomes (principally Illness Intrusiveness Rating Scale) and clinical outcomes (change in hemoglobin A1c) among patients with type 2 diabetes and hemoglobin A1c >8%.  

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Rozalina McCoy, M.D., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions